Noradrenalina Kalceks (Norepinephrine)

Noradrenalina Kalceks is used in the management of cardiovascular emergencies that involve low blood pressure or shock, where rapid elevation of arterial pressure is required.

• Hypotension: restores systemic vascular resistance to achieve target blood pressure.
• Septic shock: supports hemodynamics while underlying infection is treated.
• Cardiogenic shock: improves perfusion by increasing arterial pressure in heart‑failure‑related shock.

• Norepinephrine acts as a potent agonist at α1‑adrenergic receptors on vascular smooth muscle, causing vasoconstriction and increased systemic vascular resistance. It also stimulates β1‑adrenergic receptors in the heart, modestly enhancing cardiac contractility and heart rate. Its rapid onset after intravenous administration makes it suitable for emergency resuscitation.

Norepinephrine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: mild to moderate intensity.
• Tachycardia: increased heart rate.
• Arrhythmia: irregular cardiac rhythm.
• Nausea: gastrointestinal discomfort.
• Anxiety: feelings of nervousness.
• Tremor: fine muscle shaking.

Serious or Rare Side Effects

• Severe hypertension: dangerously high blood pressure.
• Myocardial ischemia: reduced blood flow to heart muscle.
• Peripheral tissue necrosis: damage at injection site if extravasated.
• Pulmonary edema: fluid accumulation in lungs.
• Cardiac arrest: sudden loss of heart function.
• Severe bradycardia: markedly slow heart rate.

When using Noradrenalina Kalceks, clinicians should observe several safety measures to minimize risks.

• Monitor blood pressure: adjust infusion to maintain target range.
• Assess cardiac function: avoid in patients with uncontrolled tachyarrhythmias.
• Avoid extravasation: ensure secure intravenous line and observe infusion site.
• Use with caution in peripheral vascular disease: risk of ischemia.
• Pregnancy and lactation: limited data, prescribe only if benefit outweighs risk.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with other medications, influencing its efficacy or safety.

Major Interactions (Avoid)

• MAO inhibitors: risk of hypertensive crisis.
• Tricyclic antidepressants: additive vasoconstrictive effect.
• Ergot alkaloids: severe vasospasm.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may blunt heart‑rate response.
• Other vasopressors (e.g., phenylephrine): cumulative pressor effect.
• ACE inhibitors: may enhance hypotensive episodes after discontinuation.
• Diuretics: potential for volume depletion affecting response.